Microglia and myeloperoxidase: A deadly partnership in neurodegenerative disease

Free Radical Biology and Medicine

Volumn 45, Issue 5, 2008, Pages 726-731

  Lefkowitz, Doris L ^a   Lefkowitz, Stanley S ^a  

^a UNIVERSITY OF TEXAS AT AUSTIN   (United States)

Author keywords

Alzheimer's disease; Mannose receptor; Microglia; Multiple sclerosis; Myeloperoxidase; Parkinson's disease; Reactive oxygen species; Tumor necrosis factor

Indexed keywords

AMYLOID BETA PROTEIN; CELL ADHESION MOLECULE; MANNOSE RECEPTOR; MYELOPEROXIDASE; NEUTROPHIL CYTOPLASMIC ANTIBODY; REACTIVE OXYGEN METABOLITE; TUMOR NECROSIS FACTOR ALPHA;

ALZHEIMER DISEASE; ARTICLE; DEGENERATIVE DISEASE; DISEASE ASSOCIATION; DRUG TARGETING; ENZYME ACTIVITY; HUMAN; INFLAMMATION; MICROGLIA; MULTIPLE SCLEROSIS; NEUROLOGIC DISEASE; NONHUMAN; PARKINSON DISEASE; PHAGOCYTOSIS; PRIORITY JOURNAL;

ANIMALS; BRAIN; HUMANS; LECTINS, C-TYPE; MANNOSE-BINDING LECTINS; MICROGLIA; MODELS, NEUROLOGICAL; NEURODEGENERATIVE DISEASES; PEROXIDASE; REACTIVE OXYGEN SPECIES; RECEPTORS, CELL SURFACE;

EID: 48449094379     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2008.05.021     Document Type: Article

References (76)

1. Carswell E.A., Old L.J., Kassel R.L., Green S., Fiore N., and Williamson B. An endotoxin-induced serum factor that causes necrosis of tumors. Proc. Natl. Acad. USA 72 (1975) 3666-3670
2. Brennan F.M., Maini R.N., and Feldmann M. TNF alpha-a pivotal role in rheumatoid arthritis?. Br. J. Rheumatol. 31 (1992) 293-298
3. Feldmann M., Brennan F.M., and Maini R.N. Role of cytokines in rheumatoid arthritis. Annu. Rev. Immunol. 14 (1996) 397-440
4. Burmester G.R., Stuhlmuller B., Keyszer G., and Kinne R.W. Mononuclear phagocytes and rheumatoid synovitis. Mastermind or workhorse in arthritis?. Arthritis Rheum. 40 (1997) 5-18
5. Rogler G., and Andus T. Cytokines in inflammatory bowel disease. World J. Surg. 22 (1998) 382-389
6. Beutler B.A. The role of tumor necrosis factor in health and disease. J. Rheumatol. 57 (1999) 16-21
7. Fox D.A. Cytokine blockade as a new strategy to treat rheumatoid arthritis: inhibition of tumor necrosis factor. Arch. Intern. Med. 160 (2000) 437-444
8. Ganesan S., Travis S.P., Ahmad T., and Jazrawi R. Therapeutic inhibitors of tumor necrosis factor in Crohn's disease. Curr. Opin. Invest. Drugs 3 (2002) 1301-1306
9. Bradley P.P., Christensen R.D., and Rothstein G. Cellular and extracellular myeloperoxidase in pyogenic inflammation. Blood 60 (1982) 618-622
10. Davies E.V., Williams B.D., and Campbell A.K. Synovial fluid polymorphonuclear leucocytes from patients with rheumatoid arthritis have reduced MPO and NADPH-oxidase activity. Br. J. Rheumatol. 29 (1990) 415-421
11. Dinerello C.A. Interleukin-1 and tumor necrosis factor: effector cytokines in autoimmune disease. Semin. Immunol. 4 (1992) 129-131
12. Perry V.H. The influence of systemic inflammation on inflammation in the brain: implications for chronic neurodegenerative disease. Brain Behav. Immun. 18 (2004) 407-413
13. Nagatsu T., and Sawada M. Inflammatory process in Parkinson's disease: role for cytokines. Curr. Pharm. Design 11 (2005) 999-1016
14. Weisman D., Hakimian E., and Ho G.J. Interleukins, inflammation, and mechanisms of Alzheimer's disease. Vit. Horm. 74 (2006) 505-530
15. Tarkowski E., Blennow K., Wallin A., and Tarkowski A. Intracerebral production of tumor necrosis factor-alpha, a local neuroprotective agent, in Alzheimer disease and vascular dementia. J. Clin. Immunol. 19 (1999) 223-230
16. Blasko I., Lederer W., Oberbauer H., Walch T., Kemmler G., Hinterhuber H., Marksteiner J., and Humpel C. Measurement of thirteen biological markers in CSF of patients with Alzheimer's disease and other dementias. Dement. Geriatr. Cogn. Disord. 21 (2006) 9-15
17. Akama K.T., and Van Eldik L.J. Beta-amyloid stimulation of inducible nitric-oxide synthase in astrocytes is interleukin-1beta-and tumor necrosis factor-alpha (TNFalpha)-dependent, and involves a TNFalpha receptor-associated factor-and NFkappaB-inducing kinase-dependent signaling mechanism. J. Biol. Chem. 275 (2000) 7918-7924
18. Sawada M., Imamura K., and Nagatsu T. Role of cytokines in inflammatory process in Parkinson's disease. J. Neural Transm. (2006) 373-381
19. Hendriks J.J., Teunissen C.E., de Vries H.E., and Dijkstra C.D. Macrophages and neurodegeneration. Brain Res. 48 (2005) 185-195
20. Gosselin D., and Rivest S. Role of IL-1 and TNF in the brain: twenty years of progress on a Dr. Jekyll/Mr. Hyde duality of the innate immune system. Brain Behav. Immun. 21 (2007) 281-289
21. Arnett H.A., Mason J., Marino M., Suzuki K., Matsushima G.K., and Ting J.P. TNF alpha promotes proliferation of oligodendrocyte progenitors and remyelination. Nat. Neurosci. 4 (2001) 1116-1122
22. Turrin N.P., and Rivest S. Molecular and cellular immune mediators of neuroprotection. Mol. Neurobiol. 34 (2006) 221-242
23. Simard A.R., and Rivest S. Neuroprotective properties of the innate immune system and bone marrow stem cells in Alzheimer's disease. Mol. Psychiatry 11 (2006) 327-335
24. Glezer I., Simard A.R., and Rivest S. Neuroprotective role of the innate immune system by microglia. Neuroscience 147 (2007) 867-883
25. Bergt C., Nakano T., Ditterich J., DeCarli C., and Eiserich J.P. Oxidized plasma high-density lipoprotein is decreased in Alzheimer's disease. Free Radic. Biol. Med. 41 (2006) 1542-1547
26. Clark I.A., Tumwood C.M., Chaudhri G., Cowden W.B., and Hunt N.H. Tumor necrosis factor and reactive oxygen species: Implications for free radical-induced tissue injury. Proc. Upjohn Symp., Bethesda: Fed. Am. Soc. Exp. Biol. (1987) 122-129
27. Lefkowitz D.L., Mone J., Mills K., Hsieh T.C., and Lefkowitz S.S. Peroxidases enhance macrophage-mediated cytotoxicity via induction of tumor necrosis factor. Proc. Soc. Exp. Biol. Med. 190 (1989) 144-149
28. Lefkowitz D.L., Mills K.C., Moguilevsky N., Bollen A., Vaz A., and Lefkowitz S.S. Regulation of macrophage function by human recombinant myeloperoxidase. Immunol. Lett. 36 (1993) 43-49
29. Cacquevel M., Lebeurrier N., Cheenne S., and Vivien D. Cytokines in neuroinflammation and Alzheimer's disease. Curr. Drug Targets 5 (2004) 529-534
30. 2+disturbance in microglia activation-mediated dopaminergic cell degeneration. Mech. Ageing Dev. 126 (2005) 1241-1254
31. Culmsee C., and Landshamer S. Molecular insights into mechanisms of the cell death program: role in the progression of neurodegenerative disorders. Curr. Alzheimer Res. 3 (2006) 269-283
32. Loh K.P., Huang S.H., De Silva R., Tan B.K., and Zhu Y.Z. Oxidative stress: apoptosis in neuronal injury. Curr. Alzheimer Res. 3 (2006) 327-337
33. Benveniste E.N., Nguyen V.T., and O'Keefe G.M. Immunological aspects of microglia: relevance to Alzheimer's disease. Neurochem. Int. 39 (2001) 381-391
34. Zipp F., and Aktas O. The brain as a target of inflammation: common pathways link inflammatory and neurodegenerative diseases. Trends Neurosci. 29 (2006) 518-527
35. Yap Y.W., Whiteman M., and Cheung N.S. Chlorinative stress: an under appreciated mediator of neurodegeneration?. Cell. Signal. 19 (2007) 219-228
36. Fiala M., Lin J., Ringman J., Kermani-Arab V., Tsao G., Patel A., Lossinsky A.S., Graves M.C., Gustavson A., Sayre J., Sofroni E., Suarez T., Chiappelli F., and Bernard G. Ineffective phagocytosis of amyloid-beta by macrophages of Alzheimer's disease patients. J. Alzheimers Dis. 7 221-232 (2005) 255-262 discussion
37. McGeer P.L., Itagaki S., Tago H., and McGeer E.G. Reactive microglia in patients with senile dementia of the Alzheimer type are positive for the histocompatibility glycoprotein HLA-DR. Neurosci. Lett. 79 (1987) 195-200
38. McGeer P.L., Itagaki S., Boyes B.E., and McGeer E.G. Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains. Neurology 38 (1988) 1285-1291
39. Banati R.B., Gehrmann J., Schubert P., and Kreutzberg G.W. Cytotoxicity of Microglia. Glia 7 (1993) 111-118
40. Reynolds W.F., Rhees J., Maciejewski D., Paladino T., Sieburg H., Maki R.A., and Masliah E. Myeloperoxidase polymorphism is associated with gender specific risk for Alzheimer's disease. Exp. Neurol. 155 (1999) 31-41
41. Green P.S., Mendez A.J., Jacob J.S., Crowley J.R., Growdon W., Hyman B.T., and Heinecke J.W. Neuronal expression of myeloperoxidase is increased in Alzheimer's disease. J. Neurochem. 90 (2004) 724-733
42. Choi D.K., Pennathur S., Perier C., Tieu K., Teismann P., Wu D.C., Jackson-Lewis V., Vila M., Vonsattel J.P., Heinecke J.W., and Przedborski S. Ablation of the inflammatory enzyme myeloperoxidase mitigates features of Parkinson's disease in mice. J. Neurosci. 25 (2005) 6594-6600
43. Ulvestad E., Williams K., Mork S., Antel J., and Nyland H. Phenotypic differences between human monocytes/macrophages and microglial cells studied in situ and in vitro. J. Neuropathol. Exp. Neurol. 53 (1994) 492-501
44. Pope S.K., Kritchevsky S.B., Ambrosone C., Yaffe K., Tylavsky F., Simonsick E.M., Rosano C., Stewart S., and Harris T. Myeloperoxidase polymorphism and cognitive decline in older adults in the Health, Aging, and Body Composition Study. Am. J. Epidemiol. 163 (2006) 1084-1090
45. Gray E., Thomas T.L., Betmouni S., Scolding N., and Love S. Elevated activity and microglial expression of myeloperoxidase in demyelinated cerebral cortex in multiple sclerosis. Brain Pathol. 18 (2008) 86-95
46. Yap Y.W., Whiteman M., and Cheung N.S. Chlorinative stress: an under appreciated mediator of neurodegeneration?. Cell. Signal. 19 (2007) 219-228
47. Zappia M., Manna I., Serra P., Cittadella R., Andreoli V., La Russa A., Annesi F., Spadafora P., Romeo N., Nicoletti G., Messina D., Gambardella A., and Quattrone A. Increased risk for Alzheimer disease with the interaction of MPO and A2M polymorphisms. Arch. Neurol. 61 (2004) 341-344
48. Reynolds W.F., Rhees J., Maciejewski D., Paladino T., Sieburg H., Maki R.A., and Masliah E. Myeloperoxidase polymorphism is associated with gender specific risk for Alzheimer's disease. Exp. Neurol. 155 (1999) 31-41
49. Leininger-Muller B., Hoy A., Herbeth B., Pfister M., Serot J.M., Stavljenic-Rukavina M., Massana L., Passmore P., Siest G., and Visvikis S. Myeloperoxidase G-463A polymorphism and Alzheimer's disease in the ApoEurope study. Neurosci. Lett. 349 (2003) 95-98
50. Crawford F.C., Freeman M.J., Schinka J.A., Morris M.D., Abdullah L.I., Richards D., Sevush S., Duara R., and Mullan M.J. Association between Alzheimer's disease and a functional polymorphism in the Myeloperoxidase gene. Exp. Neurol. 167 (2001) 456-459
51. Pryzwansky K.B., MacRae E.K., Spitznagel J.K., and Cooney M.H. Early degranulation of human neutrophils: immunocytochemical studies of surface and intracellular phagocytic events. Cell 18 (1979) 1025-1033
52. Rogers J., and Lue L.F. Microglial chemotaxis, activation, and phagocytosis of amyloid beta-peptide as linked phenomena in Alzheimer's disease. Neurochem. Int. 39 (2001) 333-340
53. Edwards S.W., Hughes V., Barlow J., and Bucknall R. Immunological detection of myeloperoxidase in synovial fluid from patients with rheumatoid arthritis. Biochemical J. 250 (1988) 81-85
54. Lefkowitz D.L., Gelderman M.P., Fuhrmann S.R., Graham S., Starnes III J.D., Lefkowitz S.S., Bollen A., and Moguilevsky N. Neutrophilic myeloperoxidase-macrophage interactions perpetuate chronic inflammation associated with experimental arthritis. Clin. Immunol. 91 (1999) 145-155
55. King C.C., Jefferson M.M., and Thomas E.L. Secretion and inactivation of myeloperoxidase by isolated neutrophils. J. Leukoc. Biol. 61 (1997) 293-302
56. Gelderman M.P., Stuart R., Vigerust D., Fuhrmann S., Lefkowitz D.L., Allen R.C., Lefkowitz S.S., and Graham S. Perpetuation of inflammation associated with experimental arthritis: the role of macrophage activation by neutrophilic myeloperoxidase. Mediat. Inflamm. 7 (1998) 381-389
57. Shepherd V.L., and Hoidal J.R. Clearance of neutrophil-derived myeloperoxidase by the macrophage mannose receptor. Am. J. Respir. Cell Mol. Biol. 2 (1990) 335-340
58. Lefkowitz D.L., Mills K., Morgan D., and Lefkowitz S.S. Macrophage activation and immunomodulation by myeloperoxidase. Proc. Soc. Exp. Biol. Med. 199 (1992) 204-210
59. Allavena P., Chieppa M., Monti P., and Piemonti L. From pattern recognition receptor to regulator of homeostasis: the double-faced macrophage mannose receptor. Crit. Rev. Immunol. 24 (2004) 179-192
60. Mytar B., Gawlicka M., Szatanek R., Woloszyn M., Ruggiero I., Piekarska B., and Zembala M. Induction of intracellular cytokine production in human monocytes/macrophages stimulated with ligands of pattern recognition receptors. Inflamm. Res. 53 (2004) 100-106
61. Mytar B., Woloszyn M., Macura-Biegun A., Hajto B., Ruggiero I., Piekarska B., and Zembala M. Involvement of pattern recognition receptors in the induction of cytokines and reactive oxygen intermediates production by human monocytes/macrophages stimulated with tumour cells. Anticancer Res. 24 (2004) 2287-2293
62. Zhang J., Tachado S.D., Patel N., Zhu J., Imrich A., Manfruelli P., Cushion M., Kinane T.B., and Koziel H. Negative regulatory role of mannose receptors on human alveolar macrophage proinflammatory cytokine release in vitro. J. Leukoc. Biol. 78 (2005) 665-674
63. Mander P.K., Jekabsone A., and Brown G.C. Microglia proliferation is regulated by hydrogen peroxide from NADPH oxidase. J. Immunol. 176 (2006) 1046-1052
64. Haegens A., Vernooy J.H., Heeringa P., Mossman B.T., and Wouters E.F. Myeloperoxidase modulates lung epithelial responses to pro-inflammatory agents. Eur. Respir. J. 31 (2008) 252-260
65. Grattendick K., Stuart R., Roberts E., Lincoln J., Lefkowitz S.S., Bollen A., Moguilevsky N., Friedman H., and Lefkowitz D.L. Alveolar macrophage activation by myeloperoxidase: a model for exacerbation of lung inflammation. Am. J. Respir. Cell Mol. Biol. 26 (2002) 716-722
66. Lefkowitz D.L., and Lefkowitz S.S. Macrophage-neutrophil interaction: a paradigm for chronic inflammation revisited. Immunol. Cell Biol. 79 (2001) 502-506
67. Lefkowitz D.L., Roberts E., Grattendick K., Schwab C., Stuart R., Lincoln J., Allen R.C., Moguilevsky N., Bollen A., and Lefkowitz S.S. The endothelium and cytokine secretion: the role of peroxidases as immunoregulators. Cell. Immunol. 202 (2000) 23-30
68. Regnier-Vigouroux A. The mannose receptor in the brain. Int. Rev. Cytol. 226 (2003) 321-342
69. Lincoln J.A., Lefkowitz D.L., Cain T., Castro A., Mills K.C., Lefkowitz S.S., Moguilevsky N., and Bollen A. Exogenous myeloperoxidase enhances bacterial phagocytosis and intracellular killing by macrophages. Infect. Immun. 63 (1995) 3042-3047
70. Lefkowitz S.S., Gelderman M.P., Lefkowitz D.L., Moguilevsky N., and Bollen A. Phagocytosis and intracellular killing of Candida albicans by macrophages exposed to myeloperoxidase. J. Infect. Dis. 173 (1996) 1202-1207
71. Lefkowitz D.L., Lincoln J.A., Lefkowitz S.S., Bollen A., and Moguilevsky N. Enhancement of macrophage-mediated bactericidal activity by macrophage-mannose receptor-ligand interaction. Immunol. Cell Biol. 75 (1997) 136-141
72. Gelderman M.P., Lefkowitz D.L., Lefkowitz S.S., Bollen A., and Moguilevsky N. Exposure of macrophages to an enzymatically inactive macrophage mannose receptor ligand augments killing of Candida albicans. Proc. Soc. Exp. Biol. Med. 217 (1998) 81-88
73. Heeringa P., Huugen D., and Tervaert J.W. Anti-neutrophil cytoplasmic autoantibodies and leukocyte-endothelial interactions: a sticky connection?. Trends Immunol. 26 (2005) 561-564
74. Roda J.M., Parihar R., Magro C., Nuovo G.J., Tridandapani S., and Carson III W.E. Natural killer cells produce T cell-recruiting chemokines in response to antibody-coated tumor cells. Cancer Res. 66 (2006) 517-526
75. McFarland H.F., and Martin R. Multiple sclerosis: a complicated picture of autoimmunity. Nat. Immunol. 8 (2007) 913-919
76. Sung S.S., Nelson R.S., and Silverstein S.C. Yeast mannans inhibit binding and phagocytosis of zymosan by mouse peritoneal macrophages. J. Cell Biol. 96 (1983) 160-166